BridgeBio have substantially boosted this development of the new therapy for ATTR-CM, utilizing the compound. Preliminary trial data indicates potential benefits for individuals suffering with the severe illness. The effort represents the company’s dedication to managing unmet patient demands in a cardiology arena. Attruby: BridgeBio's … Read More